Cardiac Rhythm Management Devices Market to witness major growth in coming years
Category: #business  By Rahul Varpe  Date: 2020-03-26
  • share
  • Twitter
  • Facebook
  • LinkedIn
Cardiac Rhythm Management Devices Market to witness major growth in coming years

Cardiac Rhythm Management Devices Market is expected to exceed USD 13.7 billion by 2025. Growing number of patients with recurrent arrhythmias and rising prevalence of cardiovascular diseases across the globe are some of the leading factors augmenting the demand for cardiac rhythm management devices that will further propel the market growth positively.

Some major findings of the market report include:

  • Rising demand for implantable cardiac pacemakers that assist in improving the quality of life of several patients aids in boosting the market growth
  • Growing prevalence of heart failures along with other cardiovascular diseases are one of the few factors that are driving the market growth
  • Increasing incidence of atrial fibrillation, congenital heart diseases and arrhythmias in the U.S. and growing geriatric population in the Asia Pacific region are expected to provide lucrative opportunities to industry expansion
  • Major players operating in the cardiac rhythm management devices market are Abbott, BIOTRONIK, Boston Scientific Corporation, Liva Nova etc.
  • Companies are introducing new product launches in order to gain competitive edge over the rivals

Request sample copy of this report @ https://www.decresearch.com/request-sample/detail/3933

Growing number of arrhythmia and sudden cardiac death represent a major public health problem accounting for 15-20% of all the deaths across the globe. According to an article published in the National Centre for Biotechnology and Information (NCBI), around 17 million deaths occur each year with sudden & unexpected cardiac death, of which sudden cardiac death accounts for 25% across the globe. Around 180,000-300,000 sudden cardiac deaths occur in the U.S. each year. Thus, preventive measures are being taken in order to curb the death rate that occur due to sudden cardiac death by adopting cardiac rhythm management devices that would monitor the heart beats, thereby driving the market growth positively.

Rising demand for the pacemakers to treat abnormal arrhythmias is driving the market growth and it is anticipated that pacemakers will exceed the market revenue by USD 4.3 billion in 2025. The other factors that are contributing in the pacemakers market growth are growing incidences of congestive heart failure, cardiomyopathy and bradycardia across the globe. According to the article published by the American College of Cardiology, approximately 200,000 pacemakers are implanted in the U.S. each year. Hence, owing to these statistics the market is expected to witness a lucrative growth over the forecast period.

Make Inquiry about this report @ https://www.decresearch.com/inquiry-before-buying/3933

North America dominated the global cardiac rhythm management devices market in 2018 and was valued at USD 5.7 billion. The market in the region is projected to grow at a steady rate in the upcoming years. This is attributed to the factors such as growing awareness among the population in the region, developed healthcare infrastructure, favorable reimbursement schemes and growing incidences of recurrent arrhythmia patients in the region. Hence, the above mentioned factors will result in augmenting the demand and adoption rate of cardiac rhythm management devices thereby, fueling the market growth.

Some of the key players operating in global cardiac rhythm management devices market are: Boston Scientific, BIOTRONIK, ABIOMED, SCHILLER, ZOLL Medical, Koninklijke Philips N.V., Medtronic, Abbott, among others. Players have been engaging in collaborations, acquisitions and mergers, new product launch strategies in order to expand their product portfolio and gain competitive advantage. For instance, in May 2017, BIOTRONIK announced the launch of FDA approved Cardiac rhythm management (CRM) devices with MRI AutoDetect technology that ensures patients with CRM devices can experience MRI scans while minimizing the programming burden for hospitals.

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Rahul Varpe

Rahul Varpe    

Rahul Varpe currently writes for Technology Magazine. A communication Engineering graduate by education, Rahul started his journey in as a freelancer writer along with regular jobs. Rahul has a prior experience in writing as well as marketing of services and products ...

Read More >>

More News By Rahul Varpe

Dental Practice Management Software Market is set to record 11.8% CAGR during forecast time
Dental Practice Management Software Market is set to record 11.8% CAGR during forecast time
By Rahul Varpe

The size of the Dental Practice Management Software Market was accrued at USD 1.2 billion in 2018 and is presumed to accumulate over USD 2.7 billion by the year 2025. According to research, the Dental Practice Management Software Market is expected t...

By 2025, Biosensors Market is Expected to Record 31.5 Billion Dollar Revenue
By 2025, Biosensors Market is Expected to Record 31.5 Billion Dollar Revenue
By Rahul Varpe

The Biosensors Market size was estimated at USD 18.6 billion in 2018 and is projected to surpass USD 31.5 billion by the year 2025. During the period of 2019-2025, the Biosensors Market is anticipated to expand with a CAGR of 8%. The report contain...

Breast Pump Market Recent Trends and Forecast To 2025
Breast Pump Market Recent Trends and Forecast To 2025
By Rahul Varpe

The Breast Pump Market is projected to expand from its present industry value of over $1 billion to more than $1.5 billion over the analysis timeframe. According to the study with title ‘Global Breast Pump Market Research Report’, the g...